222 related articles for article (PubMed ID: 12776775)
1. Developments in component therapy: novel components and new uses for familiar preparations.
Wright-Kanuth MS; Smith LA
Clin Lab Sci; 2002; 15(2):116-24; quiz 125-7. PubMed ID: 12776775
[TBL] [Abstract][Full Text] [Related]
2. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
Corash L
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
[TBL] [Abstract][Full Text] [Related]
3. Pathogen reduction of blood components.
Solheim BG
Transfus Apher Sci; 2008 Aug; 39(1):75-82. PubMed ID: 18602343
[TBL] [Abstract][Full Text] [Related]
4. Use of platelets and other transfusion products in patients with malignancy.
Bayer WL; Bodensteiner DC; Tilzer LL; Adams ME
Semin Thromb Hemost; 1992; 18(4):380-91. PubMed ID: 1470926
[TBL] [Abstract][Full Text] [Related]
5. Pathogen-reduction systems for blood components: the current position and future trends.
Seghatchian J; de Sousa G
Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
[TBL] [Abstract][Full Text] [Related]
6. Impact of transfusion of fresh-frozen plasma and packed red blood cells in a 1:1 ratio on survival of emergency department patients with severe trauma.
Zehtabchi S; Nishijima DK
Acad Emerg Med; 2009 May; 16(5):371-8. PubMed ID: 19302364
[TBL] [Abstract][Full Text] [Related]
7. Unappreciated risk factors for transplant patients: HLA antibodies in blood components.
Bray RA; Harris SB; Josephson CD; Hillyer CD; Gebel HM
Hum Immunol; 2004 Mar; 65(3):240-4. PubMed ID: 15041162
[TBL] [Abstract][Full Text] [Related]
8. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years?
Duchesne JC; Hunt JP; Wahl G; Marr AB; Wang YZ; Weintraub SE; Wright MJ; McSwain NE
J Trauma; 2008 Aug; 65(2):272-6; discussion 276-8. PubMed ID: 18695461
[TBL] [Abstract][Full Text] [Related]
9. Infectious complications after cardiac surgery: lack of association with fresh frozen plasma or platelet transfusions.
Sreeram GM; Welsby IJ; Sharma AD; Phillips-Bute B; Smith PK; Slaughter TF
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):430-4. PubMed ID: 16085245
[TBL] [Abstract][Full Text] [Related]
10. An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion.
Sperry JL; Ochoa JB; Gunn SR; Alarcon LH; Minei JP; Cuschieri J; Rosengart MR; Maier RV; Billiar TR; Peitzman AB; Moore EE;
J Trauma; 2008 Nov; 65(5):986-93. PubMed ID: 19001962
[TBL] [Abstract][Full Text] [Related]
11. Fresh frozen plasma should be given earlier to patients requiring massive transfusion.
Gonzalez EA; Moore FA; Holcomb JB; Miller CC; Kozar RA; Todd SR; Cocanour CS; Balldin BC; McKinley BA
J Trauma; 2007 Jan; 62(1):112-9. PubMed ID: 17215741
[TBL] [Abstract][Full Text] [Related]
12. Pediatric transfusion: considerations by age and blood component.
Glassman AB
South Med J; 1982 Jun; 75(6):722-5. PubMed ID: 6806910
[TBL] [Abstract][Full Text] [Related]
13. Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie.
Maegele M; Lefering R; Paffrath T; Tjardes T; Simanski C; Bouillon B;
Vox Sang; 2008 Aug; 95(2):112-9. PubMed ID: 18557827
[TBL] [Abstract][Full Text] [Related]
14. Update on pathogen reduction technology for therapeutic plasma: an overview.
Solheim BG; Seghatchian J
Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
[TBL] [Abstract][Full Text] [Related]
15. Testing of blood products in a polytrauma model: results of a multi-institutional randomized preclinical trial.
Alam HB; Bice LM; Butt MU; Cho SD; Dubick MA; Duggan M; Englehart MS; Holcomb JB; Morris MS; Prince MD; Schreiber MA; Shults C; Sondeen JL; Tabbara M; Tieu BH; Underwood SA;
J Trauma; 2009 Oct; 67(4):856-64. PubMed ID: 19820596
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-related acute lung injury: current concepts for the clinician.
Triulzi DJ
Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
[TBL] [Abstract][Full Text] [Related]
17. Advances in transfusion therapy.
Beck SJ
Clin Lab Sci; 1994; 7(4):225-31. PubMed ID: 10147432
[TBL] [Abstract][Full Text] [Related]
18. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections.
Roback JD; Conlan M; Drew WL; Ljungman P; Nichols WG; Preiksaitis JK
Transfus Med Rev; 2006 Jan; 20(1):45-56. PubMed ID: 16373187
[TBL] [Abstract][Full Text] [Related]
19. [Recent circumstances in the supply and demand of various blood products in Japan, and appropriate use of blood components or plasma protein derivatives].
Tohyama H
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3095-104. PubMed ID: 3777947
[TBL] [Abstract][Full Text] [Related]
20. The role and impact of the transfusion medicine consultation service in the management of patients in the hematopoietic transplant service: A retrospective analysis.
Narvios A; Rodriguez-Jackson L; Reddy V; Lichtiger B
Transfus Clin Biol; 2009 Sep; 16(4):383-7. PubMed ID: 19665413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
